

Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1225, 2008-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Adalimumab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. :


Adalimumab/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :


Adalimumab: Palmoplantar psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1430, 2012-01 ,pp. :


Adalimumab/infliximab: Psoriasis treated with ustekinumab: case report
Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. :


Adalimumab/etanercept/infliximab: Psoriasis (first report with adalimumab): 5 case reports
Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. :